首页 | 本学科首页   官方微博 | 高级检索  
     

不同血液净化方式对慢性肾功能衰竭患者树突状细胞和血小板活化标志物表达的影响
引用本文:张盛,雷莉,韩林,胡大军. 不同血液净化方式对慢性肾功能衰竭患者树突状细胞和血小板活化标志物表达的影响[J]. 疑难病杂志, 2022, 0(2): 172-177
作者姓名:张盛  雷莉  韩林  胡大军
作者单位:湖北省宜昌市第二人民医院肾内科
基金项目:湖北省卫生计生委联合基金立项项目(WJ2018MB361)。
摘    要:目的 比较血液透析(HD)、血液透析滤过(HDF)和血液灌流(HP)3种血液净化方式对慢性肾功能衰竭患者树突状细胞和血小板活化标志物表达的影响.方法 选取2020年1—12月湖北省宜昌市第二人民医院肾内科收治慢性肾功能衰竭患者106例,按照随机数字表法分为HD组(n=36)、HDF组(n=35)、HP组(n=35),相...

关 键 词:慢性肾功能衰竭  血液透析  血液透析滤过  血液灌流  树突状细胞标志物  血小板活化标志物

Effects of different blood purification methods on the expression of dendritic cells and platelet activation markers in patients with chronic renal failure
Zhang Sheng,Lei Li,Han Lin,Hu Dajun. Effects of different blood purification methods on the expression of dendritic cells and platelet activation markers in patients with chronic renal failure[J]. Journal of Difficult and Complicated Cases, 2022, 0(2): 172-177
Authors:Zhang Sheng  Lei Li  Han Lin  Hu Dajun
Affiliation:(Department of Nephrology, Yichang Second People's Hospital of Hubei Province, Hubei Province, Yichang 443000 ,China)
Abstract:Objective To compare the effects of hemodialysis(HD),hemodiafiltration(HDF)and hemoperfusion(HP)on the expression of dendritic cells and platelet activation markers in patients with chronic renal failure.Methods A total of 106 patients with chronic renal failure admitted to the Department of Nephrology of the Second People's Hospital of Yichang City,Hubei Province from January to December 2020 were selected and divided into HD group(n=36),HDF group(n=35),HP group according to the random number table method Group(n=35),received HD,HDF,HP treatment for 6 months,and compared the clinical efficacy,related biochemical indicators,dendritic cell markers,platelet activation marker levels,and complications before and after treatment among the three groups.Results The total effective rate of HDF group and HP group was higher than that of HD group(χ2/P=7.903/0.019),and there was no significant difference between HDF group and HP group(P>0.05).After treatment,the levels of serum albumin(Alb)and hemoglobin(Hb)in HDF group and HP group were higher than those in HD group,and the levels ofβ2 microglobulin(β2MG)and leptin(LEP)were lower than those in HD group(F=12.923,4.215,8.273,7.187,both P<0.001),but there was no significant difference between HDF group and HP group(P>0.05).There was no significant difference in the levels of BUN and SCr between the three groups after treatment(P>0.05).After treatment,CD1a,CD40,CD80,CD83,and CD86 in HDF group and HP group were higher than those in HD group,and platelet granule membrane glycoprotein 140(GMP140),CD61,CD62P,CD63,and P10 were lower than those in HD group(F=122.973,82.255,51.985,21.987,52.707,23.717,43.744,57.373,28.594,51.562,P<0.001),There was no significant difference between HDF group and HP group(P>0.05).The total incidence of complications in the HDF group and HP group was lower than that in the HD group(χ2/P=10.303/0.006),and there was no significant difference in the total incidence of complications between the HP and HDF groups(P>0.05).Conclusion HD,HDF and HP all have certain effects in the treatment of patients with chronic renal failure,and the efficacy of HDF and HP is better than that of HD,which can reduce complications and regulate the levels of biochemical indicators,dendritic cell markers,and platelet activation markers.The difference in effect is not obvious,and the clinical selection can be based on the actual situation of the patient.
Keywords:Chronic renal failure  Hemodialysis  Hemodiafiltration  Hemoperfusion  Dendritic cell markers  Platelet activation marker
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号